Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Titto Augustine

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Genes & Cancer|July 26, 2017
Telomere length regulation through epidermal growth factor receptor signaling in cancerTitto Augustine, Radhashree Maitra, Sanjay Goel
Frontiers in Cellular Neuroscience|February 27, 2026
Modeling pediatric brain tumors with human stem cellsNoah Burket, Titto Augustine, Jignesh Tailor
Investigational New Drugs|January 7, 2019
Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparibTitto Augustine, Radhashree Maitra, Jinghang Zhang, et al.
Oncotarget|April 20, 2017
Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancerRadhashree Maitra, Titto Augustine, Yitzchak Dayan, et al.
NPJ Precision Oncology|February 8, 2019
Immunotherapeutic advances in gastrointestinal malignanciesDevika Rao, Ruwan Parakrama, Titto Augustine, et al.
BMC Cancer|June 20, 2020
Immune characterization of metastatic colorectal cancer patients post reovirus administrationRuwan Parakrama, Elisha Fogel, Carol Chandy, et al.
International Journal of Molecular Sciences|November 27, 2019
Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal CancerRadhashree Maitra, Thongthai Thavornwatanayong, Madhu Kumar Venkatesh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2020
Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal CancerJeeshan Jiffry, Thongthai Thavornwatanayong, Devika Rao, et al.
Frontiers in Oncology|November 17, 2022
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancerTitto Augustine, Peter John, Tyler Friedman, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Genes & Cancer|July 26, 2017
Telomere length regulation through epidermal growth factor receptor signaling in cancerTitto Augustine, Radhashree Maitra, Sanjay Goel
Frontiers in Cellular Neuroscience|February 27, 2026
Modeling pediatric brain tumors with human stem cellsNoah Burket, Titto Augustine, Jignesh Tailor
Investigational New Drugs|January 7, 2019
Sensitization of colorectal cancer to irinotecan therapy by PARP inhibitor rucaparibTitto Augustine, Radhashree Maitra, Jinghang Zhang, et al.
Oncotarget|April 20, 2017
Toll like receptor 3 as an immunotherapeutic target for KRAS mutated colorectal cancerRadhashree Maitra, Titto Augustine, Yitzchak Dayan, et al.
NPJ Precision Oncology|February 8, 2019
Immunotherapeutic advances in gastrointestinal malignanciesDevika Rao, Ruwan Parakrama, Titto Augustine, et al.
BMC Cancer|June 20, 2020
Immune characterization of metastatic colorectal cancer patients post reovirus administrationRuwan Parakrama, Elisha Fogel, Carol Chandy, et al.
International Journal of Molecular Sciences|November 27, 2019
Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal CancerRadhashree Maitra, Thongthai Thavornwatanayong, Madhu Kumar Venkatesh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2020
Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal CancerJeeshan Jiffry, Thongthai Thavornwatanayong, Devika Rao, et al.
Frontiers in Oncology|November 17, 2022
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancerTitto Augustine, Peter John, Tyler Friedman, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
Pageof 1